Antiviral drugs could cut liver cancer risk from Hepatitis C
Danish researchers find antiviral therapy significantly reduces risk
Hepatitis C, a virus that is common and relatively easy to catch, leaves lifelong compromised health, in particular increasing the risk of liver cancer. Danish researchers have discovered that treatment with antiviral drugs could cut in half the risk of developing that strain of cancer.
This cute plush figure is intended to represent Hepatitis C, and the attendant danger associated with the disease.
Hepatitis C is a chronic, debilitating liver infection, which causes fatigue, muscle aches and jaundice. The disease is also a major risk factor for developing hepatocellular carcinoma, which is the most common form of liver cancer worldwide.
There is hope. Researchers now say patients who managed to keep the virus at bay with interferon drugs for six months were virtually cured, and the chances of a relapse and the development of cancer were minimal. Patients who cleared the Hepatitis C virus had an 85 percent lower risk of developing liver cancer.
To back up these findings, a group of 1174 patients who received no antiviral interferon treatment, 129 patients developed liver cancer. In a similar-sized group of patients who were treated, only 81 developed liver cancer, which was equivalent to a reduction in cancer risk of 47 percent. Both groups were monitored for between five and eight years.
Gastroenterologist at Copenhagen University Nina Kimer led the study. She says those who took the drugs, but did not have a robust response also have a lower risk of developing cancer.
"We were not the first study to show this, but our findings definitely support this hypothesis that the non-responders to treatment are also protected when they are treated," Kimer says.
Kimer says the study's findings suggest early detection and treatment of hepatitis C is very important.
"If people come into [the] hospital with stomach aches, we do not just conclude one thing. We try out many options. So the disease is diagnosed earlier," she said.
Hepatitis C usually leads to cancer by causing cirrhosis or scarring of the liver.
© 2012, Catholic Online. Distributed by NEWS CONSORTIUM.
- - -
Pope Benedict XVI's Prayer Intentions for January 2013
General Intention: The Faith of Christians. That in this Year of Faith Christians may deepen their knowledge of the mystery of Christ and witness joyfully to the gift of faith in him.
Missionary Intention: Middle Eastern Christians. That the Christian communities of the Middle East, often discriminated against, may receive from the Holy Spirit the strength of fidelity and perseverance.
Keywords: Hepatits C, antiviral therapy, liver cancer, study, Denmark
Rate This Article
Leave a Comment
More Health News
- Forget printing guns, doctors use 3D printer to save baby
- Is it really that simple? - Research suggests ordinary vitamin C kills drug-resistant TB
- Chamomile tea can be refreshing treat - as well as a safeguard against cancer, researchers say
- HIV resurgent among Navajo tribe as deadly cases spike
- UK to give cancer patients genetic analysis just like Angelina Jolie
- Vitamin D found beneficial in treating asthma symptoms
- Study: Depressed women in 40s, 50s suffer more than twice for stroke risk
- Some experts say it's biologically possible to clone a human
- Study: Women live longer than men as their immune systems age more slowly
- Fr. Paul Schenck: Finding Living Faith on Catechetical Sunday
- The Movie Yellow: Incest as 'Normal' and Cassavates's Slides Into the World of Woes
- The Chicago School Teachers Strike Reveals the Need For School Choice
- The Sexual Barbarians and the Dissolution of Culture
- The Happy Priest Challenges Us to Ask: Who is Jesus to Me?
- Michael Coren on Canadian Public Schools: Teachers, leave those kids alone
- We Cannot Ignore Our Consciences: Cardinal Dolan On Religious Liberty
- In the Face of Danger, Successor of Peter Travels to Lebanon as a Messenger of Peace
- Reflections on the Dignity and Vocation of Women: Who or What?